Rongchuang transferred the equity of Wenzhou No. 1 project company, and the transferee was Dexin real estate
According to industrial and commercial data, rongchuang recently transferred its equity of Wenzhou haokuo Enterprise Management Co., Ltd. to its partner Dexin real estate. The reporter learned that Wenzhou haokuo Enterprise Management Co., Ltd. is a project company. At present, it is developing the "rongchuang Dexin Jiangshan yunqi" project. The plot where the project is located was won by Dexin real estate with a premium rate of 50% at a price of 3.6 billion yuan in June 2020, and then introduced into rongchuang for joint development.
This text is a result of machine translation.
Related companies：
Briefing Jun 20, 2022 04:54 PM
· Technology
The official results of the French parliamentary elections were announced, and the ruling party coalition held a relatively large number of seats
In-depth
Healthcare
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
May 11, 2023 05:07 PM
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Briefing May 19, 2022 05:45 PM
· Healthcare
Shenzhen textile A: the order of line 7 is full, and the production line speed is climbing
Healthcare, Financials
Fosun Pharma Net Profit down 45% in Q1 2022 as Value of Financial Assets Slumps
Founded in 1994, Shanghai Fosun Pharma is a global pharmaceutical and health group rooted in China and driven by innovation. Its businesses include pharmaceuticals, medical devices and diagnosis, medical and health services. The group covers the pharmaceutical field through participation in Sinopharm Holdings.
Apr 27, 2022 10:55 PM
Briefing Mar 15, 2022 12:19 PM
Half day main capital net inflow of power equipment, non bank finance, selling banks, etc
Briefing Feb 17, 2022 10:08 AM
Yingsi intelligence and Fosun Pharmaceutical reached the first milestone of strategic cooperation: nomination and targeting cd47-sirp α Small molecule compounds of signal pathway
See more
Read next
Insight
In-depth
Automotive · Analysis
How Malaysia Became Southeast Asia’s “Computing Power Hub”
Jan 07, 2026 12:24 PM
Insight
In-depth
Automotive · Analysis
Consumer-Grade 3D Printing Going Global Is Reaching a Watershed
Dec 29, 2025 05:40 PM
Insight
In-depth
Automotive · Analysis
Unpacking China | Key Chinese Firms to Watch This Week （14/12/2025-20/12/2025）
Dec 19, 2025 03:50 PM
Insight
In-depth